Navigation Links
Intercell AG: Novel tuberculosis Vaccine Shows Promising,Immunogenicity and Safety Profile

» The Danish Statens Serum Institut (SSI) and Intercell report promising data
from a phase I clinical trial with a tuberculosis (TB) subunit vaccine

» The vaccine is produced by SSI and contains Intercell’s adjuvant IC31™

» The project which is supported by the European Union aims to either
replace the available TB vaccine “BCG”/“Calmette vaccine” or to
boost its activity in adults.

COPENHAGEN, Vienna, March 14, 2007 – Statens Serum Institut (SSI) and Intercell announced today that their collaborative novel tuberculosis (TB) vaccine is safe and very immunogenic in healthy individuals in a phase I clinical trial. The preliminary data will be presented on the Keystone Symposia on Tuberculosis in Vancouver, March 24, 2007 by Prof. Peter Andersen from the SSI and April 12, 2007 at the 3rd Vienna Vaccines Conference by co-investigator Prof. Tom Ottenhoff, Leiden University Medical Center, Netherlands. Based on these results the partners will initiate a clinical trial with latent TB-infected and BCG-vaccinated individuals later in 2007.

The new H1 vaccine from SSI is a recombinant subunit vaccine based on two important TB antigens resulting from SSI’s research pipeline combined with Intercell’s proprietary adjuvant IC31™. The phase I clinical trial was performed at the Department of Infectious Diseases (headed by Prof. Jaap van Dissel) at Leiden University Medical Center in the Netherlands and was supported by the European Union–funded program “TB-VAC”.

“The successfu
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
9. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
10. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
11. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
Post Your Comments:
(Date:9/17/2014)... Sept. 17, 2014   GS1 US ... implement GS1 Standards to support the 2013 Drug ... safety and security in the pharmaceutical supply chain. ... to U.S. Pharmaceutical Supply Chain Business Processes to ... was developed in collaboration with GS1 Healthcare ...
(Date:9/17/2014)... -- Sutro Biopharma, a biopharmaceutical company developing antibody drug ... Merck KGaA, Darmstadt, Germany , which ... States and Canada , ... antibody drug conjugates (ADCs). ADCs are composed of an ... thought to specifically target and deliver the cytotoxic drug ...
(Date:9/17/2014)... ARMONK, N.Y. , Sept. 17 2014 ... Caris Life Sciences is using IBM technical computing ... profiling services for cancer patients. These services deliver ... therapeutic plans for each patient,s unique cancer, which ... costs to the healthcare system in general. ...
Breaking Medicine Technology:New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 2Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 3Sutro Biopharma and Merck KGaA of Darmstadt, Germany, to Partner on Development of Antibody Drug Conjugates 4Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4
... MALVERN, Pa., May 17, 2012  Egalet Ltd., a privately ... and abuse-deterrent medications, announced today Bob Radie, president and ... Life Sciences Europe conference on May 23 organized ... the company,s patented technology and pipeline of abuse-deterrent opioids ...
... LOUIS, May 17, 2012 , "9 Trends" ... , Helping Members Make Healthier Decisions , ... , Developing New Ways to Comprehensively Manage Specialty Care ... Poor health choices add billions in cost to ...
Cached Medicine Technology:Egalet to Present at Life Sciences Europe Conference 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 2Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 3Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 4Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers 5
(Date:9/17/2014)... Dennis Thompson HealthDay ... -- Diabetics and dieters who turn to artificial sweeteners ... themselves any favors, a new Israeli study suggests. ... despite containing no calories, researchers found in human and ... appear to alter the bacteria residing in the intestines ...
(Date:9/17/2014)... more than 87,000 men, a global team of scientists ... common differences in the genetic code -- that increase ... believed to be the largest of its kind, has ... array of ethnic groups comprising men of European, African, ... from smaller studies, according to William B. Isaacs, Ph.D., ...
(Date:9/17/2014)... Mercy “topped out” the world’s first ... beam into place. Sister of Mercy Claudia Ward also ... and video of the event, including footage from an ... http://bit.ly/MercyVirtual .) , “The topping out means we are ... thousands of patients regardless of the hour or location,” ...
(Date:9/17/2014)... Fremont, California (PRWEB) September 17, 2014 ... remote access connectivity solutions, today announced that it ... Appliance in October 2014. This new offering will ... 365 and other Software-as-a-Service applications to enable secure ... With the rise of cloud computing, there has ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. ... companies have made good on their pledge to cut calories ... companies, acting together through the Healthy Weight Commitment Foundation, pledged ... and 2012 and 1.5 trillion by 2015. They,ve actually reduced ... met their pledge and exceeded their pledge," said lead researcher ...
Breaking Medicine News(10 mins):Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 2Health News:Artificial Sweeteners May Raise Blood Sugar Levels: Study 3Health News:Large study reveals new genetic variants that raise risk for prostate cancer 2Health News:Mercy Tops Out World's First Virtual Care Center 2Health News:Celestix Announces Availability of ADFS Bridge Appliance in October 2014 to Simplify the Configuration of Office 365 with Active Directory 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 2Health News:Major U.S. Food Makers Cut 6.4 Trillion Calories From Products: Report 3
... Kiley Carlson of Sioux City, IA will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Carlson, 16, is one ... in Kids Speak Up! , a national program ...
... Findings of Pilot Study at East African Health Conference ... Danya International, Inc. (Danya), a communications, research, ... pilot study on the effectiveness of mobile video-enabled phones ... tuberculosis (TB) patients during the 3rd East African Health ...
... Milwaukee MD Saves Patients Money and Improves Health ... To save you money and save your ... may need to be part medical detective as ... http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-a ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090323/NY86411-b ...
... HOUSTON - Just more than one year after it was ... of Texas M. D. Anderson Cancer Center has introduced a ... generations of women scientists to come. , Legends and ... D. Anderson Cancer Center presents the reflections of 26 current ...
... statutory health insurances in Germany have offered an endoscopic ... all insured persons from the age of 55. Germany ... for bowel cancer a part of its statutory early ... Professor Hermann Brenner at DKFZ have now published a ...
... Scientists at the University of Liverpool have demonstrated how ... be a source of Salmonella transmission to ... living creatures that can contaminate almost any food type, ... that Salmonella which can also cause ...
Cached Medicine News:Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 2Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 3Health News:Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients 4Health News:Saving Money While Protecting Your Health in Tough Economic Times 2Health News:Saving Money While Protecting Your Health in Tough Economic Times 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 2Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 3Health News:New book chronicles the journeys of women physicians and scientists to fighting cancer 4Health News:Germany: Colonoscopy prevents 15,000 cancer cases 2Health News:Study shows how Salmonella survives in environment 2
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free....
Black elastomer. Smooth finish. Non-Sterile....
Guedel-style enclosed center channel. Semirigid, nontoxic polyethylene with color-coded bite block. Individually packaged, 48 per case. Latex Free....
Includes one of each size airway. Plastic. Color coded for size. Single use. Non-Sterile....
Medicine Products: